VDLIN:,.

Xuefei Guo1, Yang Zhao1, Xianle Rong2

  • 1Institute of Systems Biomedicine, Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, NHC Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, 100191, China.

概括

甲基可巴胺 (MCB) 降低了炎症,但削弱了天生的免疫力. 一种新的化合物Co7平衡了这些影响,为炎症性疾病和COVID-19提供了有前途的治疗方法.